Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response
<p><strong>Objectives</strong> We aimed to determine whether changes in acute severe colitis (ASC) management have translated to improved outcomes and to develop a simple model predicting steroid non-response on admission.</p> <p><strong>Design</strong> Out...
Главные авторы: | Adams, A, Gupta, V, Mohsen, W, Chapman, TP, Subhaharan, D, Kakkadasam Ramaswamy, P, Kumar, S, Kedia, S, McGregor, CG, Ambrose, T, George, BD, Palmer, R, Brain, O, Walsh, A, Ahuja, V, Travis, S, Satsangi, J |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
BMJ Publishing Group
2022
|
Схожие документы
-
Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic
по: McGregor, CG, и др.
Опубликовано: (2021) -
DEPTH OF REMISSION MAY NOT PREDICT OUTCOME OF UC OVER 2 YEARS
по: Burger, D, и др.
Опубликовано: (2011) -
Predicting outcome in acute severe colitis-controversies in clinical practice in 2021
по: Gupta, V, и др.
Опубликовано: (2021) -
Development of an index that predicts escalation of therapy at an outpatient appointment in patients with known ulcerative colitis (UC)
по: Walsh, A, и др.
Опубликовано: (2018) -
TrueColours ulcerative colitis (TCUC): Will patients with UC complete digital questionnaires in real-time?
по: Walsh, A, и др.
Опубликовано: (2018)